Giving Back at M+

Giving Back at M+

Giving is part of how we show up for the people and communities around us. Each year, our team rides with Cycle for Survival to fund rare cancer research at Memorial Sloan Kettering. Learn more and make a tax-deductible gift to support our 2027 ride.

2022
2022

Start year

$350k+
$350k+

Raised by M+

100%
100%

Funds to MSK

MassMutual Advisors:

Click here to double your donation.

Why C4S

"I lost my dad to
stomach cancer in 2024."

Why C4S

DEAR FRIENDS,

Many of you know I lost my dad to stomach cancer in 2024.

He was diagnosed with stage four in 2021. It was Dr. Janjigian and her research team at Memorial Sloan Kettering who gave him a few more years. If you or your family have been touched by cancer, you know how treasured those extra years, weeks, days, hours, and seconds can be.

I am so grateful for every extra moment MSK gave our family with my dad. 

You’ve probably also heard about my daughter, Hana. In 2025, my wife, Manjola, and I found out we were expecting her. Pure joy.

But then came a call from my father-in-law’s doctor. He had stomach cancer too.

Two dads, both with rare cancer.

While Manjola sat beside her dad during his chemotherapy, she felt Hana’s first kicks. It wasn’t exactly the setting she pictured for that moment. Cancer has a way of complicating traditionally joyous occasions. But thanks to her father’s surgeon, Dr. Lou, and the care he received, Manjola’s dad is here with us today, happily settling into his new role as a grandfather.

Gjyshi, as her Albanian family has taught Hana to call him, is here for every milestone. What more can we ask for? 

Each year, our team at M+ rides with Cycle for Survival. Every dollar raised goes directly to rare cancer research and clinical trials at Memorial Sloan Kettering. That research gave my family more time together, and it offers the same gift to so many other families.

This year, our goal is $180,000. I would be so grateful for your support. Any amount makes a difference, and it would mean the world to me, my family, and the entire M+ team. 

Your support is a gift measured in more years, weeks, days, hours, and seconds.

Thank you, and here’s to more time with the people we love,

Kuldeep

DEAR FRIENDS,

Many of you know I lost my dad to stomach cancer in 2024.

He was diagnosed with stage four in 2021. It was Dr. Janjigian and her research team at Memorial Sloan Kettering who gave him a few more years. If you or your family have been touched by cancer, you know how treasured those extra years, weeks, days, hours, and seconds can be.

I am so grateful for every extra moment MSK gave our family with my dad. 

You’ve probably also heard about my daughter, Hana. In 2025, my wife, Manjola, and I found out we were expecting her. Pure joy.

But then came a call from my father-in-law’s doctor. He had stomach cancer too.

Two dads, both with rare cancer.

While Manjola sat beside her dad during his chemotherapy, she felt Hana’s first kicks. It wasn’t exactly the setting she pictured for that moment. Cancer has a way of complicating traditionally joyous occasions. But thanks to her father’s surgeon, Dr. Lou, and the care he received, Manjola’s dad is here with us today, happily settling into his new role as a grandfather.

Gjyshi, as her Albanian family has taught Hana to call him, is here for every milestone. What more can we ask for? 

Each year, our team at M+ rides with Cycle for Survival. Every dollar raised goes directly to rare cancer research and clinical trials at Memorial Sloan Kettering. That research gave my family more time together, and it offers the same gift to so many other families.

This year, our goal is $180,000. I would be so grateful for your support. Any amount makes a difference, and it would mean the world to me, my family, and the entire M+ team. 

Your support is a gift measured in more years, weeks, days, hours, and seconds.

Thank you, and here’s to more time with the people we love,

Kuldeep

"I lost my dad to
stomach cancer in 2024."

"I lost my dad to
stomach cancer in 2024."

Listen to Manjola Tell the Story:

Listen to Manjola Tell the Story:

Our Mission

About Cycle for Survival + MSK

About Cycle for Survival + MSK

Rare cancer research is significantly underfunded. As MSK’s official rare cancer fundraising program, Cycle for Survival helps fill the funding gap. Since 2007, this community has enabled hundreds of doctors and scientists at MSK to pursue bold ideas that continue to transform how rare cancers are diagnosed and treated.

About half of all people with cancer have a rare form of the disease. Rare cancers include many types you’ve likely heard of, such as leukemia and lymphoma; thyroid, ovarian, brain, and pancreatic cancers; and all pediatric cancers.

Your donation will be allocated within six months after fundraising ends. Not only does Cycle for Survival fund critical research, it also makes sure that donated dollars get into the hands of MSK experts as quickly as possible.

The Mission

The people of MSK are united by a singular mission: ending cancer for life.

MSK is a global leader in cancer research, care, and education. Every dollar raised by Cycle for Survival provides MSK doctors and scientists with resources needed to make new discoveries in rare cancer research that benefit people all over the world.

$450M+

Raised since 2007

100%

Funds rare cancer research

100+

Clinical trials supported

6

FDA-approved treatments

OUR RIDE

We're Riding on World Cancer Day

Thursday, February 4, 5:00 to 9:00 PM at Equinox Brookfield Place

Clean water

Boreholes · Taps · Filters

We drill boreholes and install filtration systems so families no longer walk hours for safe drinking water.

Learn more

Nutrition

School meals · Food packs · Gardens

School feeding and family food packs that keep children healthy, focused and growing strong.

Learn more

Education

Books · Teachers · Classrooms

Books, teacher training and safe classrooms so every child can learn, dream and thrive.

Learn more

Clean water

Boreholes · Taps · Filters

We drill boreholes and install filtration systems so families no longer walk hours for safe drinking water.

Learn more

Nutrition

School meals · Food packs · Gardens

School feeding and family food packs that keep children healthy, focused and growing strong.

Learn more

Education

Books · Teachers · Classrooms

Books, teacher training and safe classrooms so every child can learn, dream and thrive.

Learn more

Clean water

Boreholes · Taps · Filters

We drill boreholes and install filtration systems so families no longer walk hours for safe drinking water.

Learn more

Nutrition

School meals · Food packs · Gardens

School feeding and family food packs that keep children healthy, focused and growing strong.

Learn more

Education

Books · Teachers · Classrooms

Books, teacher training and safe classrooms so every child can learn, dream and thrive.

Learn more

Double your Impact

MassMutual: How to Match

Eligible MassMutual financial professionals can request a donation match by accessing the Community Investment Portal, uploading a donation receipt, and adding “Team M+” in the “Comments to Charity” section.

Considerations


  • “Comments to Nonprofit” is necessary for Sloan Memorial to attribute the donation to the campaign; comments to the administrator are visible only to our team.

  • CIP is SSO-enabled, so only eligible qualifiers can access it.

  • Some advisors may expect access but are not eligible (e.g., Leaders Staff Titles or Rising Leaders who are not qualifiers).

  • If an advisor cannot access CIP, direct them to the program guidelines and have them contact program support with eligibility questions.

Thank You

Key Impacts from Cycle for Survival

Our work makes a difference.

Since 2007, the Cycle for Survival community has raised more than $450 million, with 100% of every dollar raised supporting rare cancer research at Memorial Sloan Kettering.

The 2026 season alone raised more than $38 million.

Cycle for Survival funding has supported more than 100 clinical trials, along with major rare cancer research initiatives at MSK.

Approximately 50% of cancer diagnoses are considered rare cancers, yet these diseases have historically received less research funding and often have fewer treatment options.

Cycle for Survival supported research contributed to six FDA-approved treatments for people with rare cancers.